Extended-release buprenorphine effectively reduced opioid use and improved treatment retention while also offsetting initial medication costs.

GLP-1RAs were associated with improved quality of life and emotional eating behaviors among individuals with overweight and obesity.

For patients undergoing noncardiac surgery, neurocognitive outcomes do not differ with hypotension-avoidance and hypertension-avoidance strategies.

Diagnosis of primary open-angle glaucoma (POAG) is associated with a reduction in mental health scores, according to a study.

Psilocybin therapy improved cognitive performance, reduced mood dysfunction, motor, and nonmotor symptoms in patients with Parkinson disease.

Compared to neurotypical individuals, standardized CBT-I for individuals with developmental disorders did not perform nearly as well.

Most individuals in the United States with cannabis use disorder (CUD) do not receive treatment, according to a study.

Both continuous positive airway pressure (CPAP) and tirzepatide are acceptable treatments for comorbid obesity and obstructive sleep apnea (COBOSA), with providers favoring CPAP and patients ...